Use of hCG and LH in controlled ovarian hyperstimulation

Details for Australian Patent Application No. 2002324183 (hide)

International Classifications

Event Publications

16 January 2003 Complete Application Filed

Priority application(s): 01307757.3 12.09.01 EP; 01307758.1 12.09.01 EP

19 June 2003 Application Open to Public Inspection

Published as AU-B-2002324183

18 October 2007 Amendment Made

The nature of the amendment is: Add priority details 01307757.3 12 Sep 2001 EP 2002367637 Megabase Research Products The nature of the amendment is as shown in the statement(s) filed 07 May 2007 2004

25 October 2007 Assignment before Grant

Applied Research Systems ARS Holding N.V The application has been assigned to Laboratoires Serono SA

25 October 2007 Application Accepted

Published as AU-B-2002324183

21 February 2008 Standard Patent Sealed

4 June 2009 Assignment Registered

Laboratoires Serono SA The patent has been assigned to Merck Serono SA

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.